Morgan Stanley Offers Pre-2Q Thoughts on Monsanto Company

In a report published Thursday, Morgan Stanley analyst Vincent Andrews reiterated an Overweight rating and $150.00 price target on Monsanto Company MON. In the report, Morgan Stanley noted, “F2Q buy side expectations appear below consensus but largely inline with our own due to a weather timing shift into F3Q. A modest bump to both the low and the high end of guidance is likely, but we do not anticipate a material guidance upgrade until F3Q reporting when all of the seed is planted.” Monsanto Company closed on Wednesday at $111.72.